| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Robert H Christenson | |
| Hassan M E Azzazy | |||
| Maurice M A L Pelsers | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fatty acid | Q61476 |
| P304 | page(s) | 19-29 | |
| P577 | publication date | 2005-11-03 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications | |
| P478 | volume | 52 |
| Q46516544 | A proteomic study of the effects of ramipril on post-infarction left ventricular remodelling in the rabbit. |
| Q36885466 | A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats |
| Q37765286 | Biomarkers of vulnerable plaque: the missing link with ischemia. |
| Q64085103 | Blood Biomarkers for Traumatic Brain Injury: A Quantitative Assessment of Diagnostic and Prognostic Accuracy |
| Q33651947 | Correlation of heart-type fatty acid–binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk |
| Q35623487 | Diagnosis of Non-ST-Elevation Acute Coronary Syndrome by the Measurement of Heart-Type Fatty Acid Binding Protein in Serum: A Prospective Case Control Study |
| Q46783761 | Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of cardiac damage in patients with obstructive sleep apnea syndrome |
| Q36127849 | Evidence for Acute Myocardial and Skeletal Muscle Injury after Serial Transthoracic Shocks in Healthy Swine. |
| Q37208848 | Free fatty acids as a cardiovascular risk factor |
| Q37919535 | Gender-specific differences in biomarkers responses to acute coronary syndromes and revascularization procedures |
| Q83393583 | Heart fatty acid-binding protein may not be an early biomarker for anthracycline-induced cardiotoxicity in rabbits |
| Q36614485 | Heart type fatty acid binding protein response and subsequent development of atherosclerosis in insulin resistant polycystic ovary syndrome patients. |
| Q33776020 | Heart-Type Fatty Acid Binding Protein Level as a Tool in Identification of Early Cardiac Effects of Diabetic Ketoacidosis |
| Q34425241 | Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery |
| Q45907477 | High peripheral levels of h-FABP are associated with poor prognosis in end-stage heart failure patients with mechanical circulatory support. |
| Q36931261 | Increase in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction |
| Q39968283 | Increases in serum concentration of human heart-type fatty acid-binding protein following elective coronary intervention |
| Q37071026 | Inosine and hypoxanthine as novel biomarkers for cardiac ischemia: from bench to point-of-care |
| Q22337035 | Is there a fatty acid taste? |
| Q35662925 | Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I. |
| Q39016250 | Key Questions for Translation of FFA Receptors: From Pharmacology to Medicines |
| Q40398087 | LysoPCs induce Hck- and PKCδ-mediated activation of PKCγ causing p47phox phosphorylation and membrane translocation in neutrophils |
| Q35090466 | Lysophosphatidylcholines activate G2A inducing G(αi)₋₁-/G(αq/)₁₁- Ca²(+) flux, G(βγ)-Hck activation and clathrin/β-arrestin-1/GRK6 recruitment in PMNs. |
| Q37288808 | Oral thresholds and suprathreshold intensity ratings for free fatty acids on 3 tongue sites in humans: implications for transduction mechanisms |
| Q36943516 | Perioperative heart-type fatty acid binding protein levels in atrial fibrillation after cardiac surgery |
| Q37429551 | Plasma free Fatty Acid concentrations as a marker for acute myocardial infarction |
| Q34097486 | Point-of-care test of heart-type fatty acid-binding protein for the diagnosis of early acute myocardial infarction |
| Q48225373 | Predictive value of heart-type fatty acid-binding protein for left ventricular remodelling and clinical outcome of hypertensive patients with mild-to-moderate aortic valve diseases |
| Q34217320 | Preoperative serum h-FABP concentration is associated with postoperative incidence of acute kidney injury in patients undergoing cardiac surgery |
| Q81618561 | Relationship between arterial stiffness and myocardial damage in patients with newly diagnosed essential hypertension |
| Q38373055 | Review on cardiovascular risk prediction |
| Q27007849 | Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients |
| Q38943061 | The Pancreatic β-Cell: A Bioenergetic Perspective |
| Q84638957 | The role of heart-type fatty acid-binding protein in predicting properties of coronary atherosclerosis in patients with acute coronary syndrome |
| Q35139560 | Utility of Heart-type Fatty Acid Binding Protein as a New Biochemical Marker for the Early Diagnosis of Acute Coronary Syndrome |
| Q50730906 | Vasculo-protective effect of BMS-309403 is independent of its specific inhibition of fatty acid-binding protein 4. |
| Q64108208 | Worsening renal failure in patients with acute heart failure: the importance of cardiac biomarkers |
Search more.